Huron Consulting Group (HURN) versus Avalon Globocare (AVCO) Critical Analysis

Huron Consulting Group (NASDAQ:HURN) and Avalon Globocare (OTCMKTS:AVCO) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Profitability

This table compares Huron Consulting Group and Avalon Globocare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Huron Consulting Group -2.23% 8.93% 4.40%
Avalon Globocare -365.09% -81.16% -44.88%

Valuation and Earnings

This table compares Huron Consulting Group and Avalon Globocare’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Huron Consulting Group $807.74 million 1.48 -$170.11 million $2.15 24.72
Avalon Globocare $1.08 million 172.46 -$3.46 million N/A N/A

Avalon Globocare has lower revenue, but higher earnings than Huron Consulting Group.

Volatility and Risk

Huron Consulting Group has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500. Comparatively, Avalon Globocare has a beta of -2.03, meaning that its share price is 303% less volatile than the S&P 500.

Institutional and Insider Ownership

86.8% of Huron Consulting Group shares are held by institutional investors. 2.7% of Huron Consulting Group shares are held by company insiders. Comparatively, 75.0% of Avalon Globocare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Huron Consulting Group and Avalon Globocare, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Huron Consulting Group 0 0 3 0 3.00
Avalon Globocare 0 0 0 0 N/A

Huron Consulting Group presently has a consensus price target of $54.33, indicating a potential upside of 2.25%. Given Huron Consulting Group’s higher possible upside, research analysts clearly believe Huron Consulting Group is more favorable than Avalon Globocare.

Summary

Huron Consulting Group beats Avalon Globocare on 8 of the 11 factors compared between the two stocks.

Huron Consulting Group Company Profile

Huron Consulting Group Inc., a professional services firm, provides advisory, technology, and analytic solutions in the United States and internationally. Its Healthcare segment provides advisory services in the areas of strategy, care transformation, financial and operational performance, technology and analytics, and leadership development to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. The company's Education segment offers management consulting and technology solutions related to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance for higher education institutions and academic medical centers. Its Business Advisory segment provides enterprise performance management, enterprise resource planning, business intelligence and analytics, customer relationship management, and data management services; and capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory services. This segment also provides strategic solutions in the areas of R&D and product strategy commercial segmentation, corporate and financial strategy, compliance and operations, reimbursement and access strategy, commercial contracting strategy, fair market value analysis, lifecycle management, litigation and investigations, government pricing and transparency reporting, auditing and monitoring, and business process improvement. The company serves healthcare, education, pharmaceutical and medical device, financial services, energy and utilities, retail, aerospace, automotive, technology, telecommunications, consumer products, governmental, metals and mining, engineering and construction, hospitality and gaming, logistics, and manufacturing industries. Huron Consulting Group Inc. was founded in 2002 and is headquartered in Chicago, Illinois.

Avalon Globocare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology, as well as rehabilitation medicine. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products to hospitals, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.

Receive News & Ratings for Huron Consulting Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huron Consulting Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply